Search

everythinglearnresearchcommunity

for

Search:↓

Sertoliform endometrioid carcinoma of the ovary, though rare, has a good prognosis when treated early.

Benign skin adnexal tumors are more common than malignant ones, with trichoepithelioma and chondroid syringoma being the most frequent types.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

The document explains various skin conditions and their treatments.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

The document reports unique growth lines in a child after Stevens-Johnson syndrome, skin reaction from parsnips and sun in a girl, and itchy skin with xanthomas in a boy with Alagille syndrome.

Finasteride helps increase or maintain hair in most men but can cause sexual side effects and should not be used by women, especially during pregnancy.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Hair color production in mice is closely linked to the hair growth phase and may also influence hair growth itself.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

Melatonin may benefit skin health and could be a promising treatment in dermatology.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Hair color production is closely linked to the active growth phase of hair in mice and may also influence hair growth itself.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Voriconazole can cause serious side effects, especially in long-term use.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Jasmonic acid and its derivatives play important roles in plant health and have potential uses in medicine and agriculture.

Pregnancy causes skin changes like darkening, hair thickening, nail changes, and increased risk of skin growths, most of which usually resolve after birth.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

Most patients treated with low-dose alpha-interferon for malignant melanoma experienced skin side effects, with hair loss being the most frequent.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.